Nexvet Biopharma Archives - Irrus Investments

Nexvet Biopharma Announces Creation of 30 New Jobs

2018-08-01T14:58:27+01:00

Careers Portal - 30 New Jobs with Animal Healthcare Group Nexvet Please link to the article below which was posted in Sept 2015 by careersportal.ie website. More good news from Nexvet Biopharma, the Irish animal healthcare group which focuses on the health of companion animals. They have acquired a manufacturing plant inTullamore and plan to create 30 new jobs over the next 12 months. Nexvet will manufacture biopharmaceutical drugs, initially for clinical trials and later, if successful, for commercial product. You can read the full article by clicking on the button below. Careers Portal - "30 New Jobs with [...]

Nexvet Biopharma Announces Creation of 30 New Jobs2018-08-01T14:58:27+01:00

Nexvet Biopharma and Zenoaq R&D Agreement

2018-08-01T14:56:28+01:00

Zenoaq - Research and Development Agreement with Nexvet Please link to the pdf below which was published in July 2015 by zenoaq.jp website. Zenoaq are a Japanese company who are involved in the development, manufacturing, import, export and sales of veterinary pharmaceuticals, biologics and medical devices. In July 2015 Zenoaq announced that it has signed a Research and Development Agreement with Nexvet Biopharma (Ireland) to develop a number of therapeutic biologics for companion animals. You can read the full articles by clicking on the buttons below. Zenoaq Announcement - "Zenoaq and Nexvet Enter Research and Development Collaboration" [...]

Nexvet Biopharma and Zenoaq R&D Agreement2018-08-01T14:56:28+01:00

DLA Piper represented Nexvet Biopharma in IPO

2018-08-01T14:37:43+01:00

DLA Piper - advises on Nexvet Biopharma IPO Please link to the article below which was posted in Feb 2015 by dlapiper.com website. In further news on Nexvet Biopharma, the Irish biopharmaceutical company which focuses on the health of companion animals, DLA Piper announced that it represented the company in it's US$40m IPO. You can read the full article by clicking on the button below. DLA Piper News - "DLA Piper advises on Nexvet Biopharma IPO"

DLA Piper represented Nexvet Biopharma in IPO2018-08-01T14:37:43+01:00